Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIH subunit 2-like protein (GTF2H2C) is a component of the core TFIIH basal transcription factor complex. It is predicted to enable zinc ion binding, participate in nucleotide excision repair (NER) of DNA, and play a role in the regulation of transcription by RNA polymerase II. GTF2H2C is localized to nuclear specks, functions in the assembly of the TFIIH complex, and interacts with other components integral to transcription and DNA repair[1][2][3][5].\n\nInterpretation notes:\n- GTF2H2C is primarily a structural and regulatory component of the TFIIH complex necessary for gene transcription and DNA repair; there is no robust evidence supporting its use as a direct therapeutic target, receptor, or druggable protein[1][2][3][5].\n- No documented direct drug interactions, mechanisms of action, biomarkers, or therapy-linked safety concerns were found in the available search results.\n- The gene may have disease relevance due to its role in DNA repair and gene regulation, but it is not considered a primary disease target or clinically actionable biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIH subunit 2-like protein (GTF2H2C).